Long-term results of a hydroxyapatite-coated femoral component in total hip replacement. A 15- to 21-year follow up study
Rajaratnam, S.S., Jack, C., Tavakkolizadeh, A., George, M.D., Fletcher, R.J., Hankins, M. and Sheppard, J.A.N. (2008) Long-term results of a hydroxyapatite-coated femoral component in total hip replacement. A 15- to 21-year follow up study. The Journal of Bone and Joint Surgery, 90-B, (1), 27-30. (doi:10.1302/0301-620X.90B1.19731). (PMID:18160495).
Full text not available from this repository.
Between 1986 and 1991 we implanted 331 consecutive Furlong hydroxyapatite-coated femoral components of a total hip replacement in 291 patients. A cemented acetabular prosthesis was used in 217 hips and a hydroxyapatite-coated component in 114. We describe the long-term clinical and radiological survival of the femoral component at a mean follow-up of 17.5 years (15 to 21). Only two patients (0.68\%) were lost to follow-up. With revision of the femoral component for any reason as the endpoint, the survival at a mean of 17 years was 97.4\% (95\% confidence interval 94.1 to 99.5), and with revision for aseptic loosening as the endpoint it was 100\%. The survival at a maximum of 21 years with revision of the femoral component for any reason as the endpoint was 97.4\% (95\% confidence interval 81.0 or 99.5). These results compare favourably with the best long-term results of cemented or uncemented femoral components used in total hip replacement.
|Subjects:||R Medicine > RD Surgery|
|Divisions:||Faculty of Health Sciences
|Date Deposited:||17 Oct 2012 10:06|
|Last Modified:||27 Mar 2014 20:26|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)